Antibodies Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Monoclonal Antibodies, Polyclonal Antibodies, ADCs, Others); Technology (Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Others); Application (Proteomics, Drug Development, Genomics); End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, CRO's), and Geography (North America, Europe, Asia Pacific, and South and Central America)

MARKET OVERVIEW

Immunoglobulins (Ig) are another name for antibodies (Ab). These are big, Y-shaped proteins produced predominantly by plasma cells in the bloodstream in response to pathogens like viruses and bacteria. Antibodies have the ability to recognise specific molecules associated with hazardous substances. Antibodies are employed in the treatment of non-Hodgkin lymphoma, asthma, psoriasis, macular degeneration, rheumatoid arthritis, hypercholesterolemia, Crohn's disease, and as well as in the diagnosis of these diseases.

MARKET SCOPE

The "Global Antibodies Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antibodies market with detailed market segmentation by type, technology, application, end user, and geography. The report provides key statistics on the market status of the leading antibodies market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on type, the market is bifurcated into monoclonal antibodies, polyclonal antibodies, ADCs, and others
  
•   Based on technology, the market is bifurcated into western blotting, flow cytometry, elisa, immunohistochemistry, immunofluorescence, immunoprecipitation, and others
  
•   Based on application, the market is bifurcated into proteomics, drug development, and genomics
  
•   Based on end user, the market is bifurcated into pharmaceutical and biotechnology companies, academic and research institutes, and CRO's
  

MARKET DYNAMICS

Drivers:

•   Increasing funding on R&D activities
  
•   Growing industry-academia collaboration
  

Restraints:

•   Quality concerns and a lack of reproducible results
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antibodies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antibodies market in these regions.

IMPACT OF COVID-19 ON ANTIBODIES MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the antibodies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antibodies market are anticipated to lucrative growth opportunities in the future with the rising demand for health coach in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antibodies market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Merck KGaA
  
•   Cell Signaling Technology, Inc.
  
•   BD
  
•   F. Hoffmann-La Roche Ltd
  
•   Bio-Rad Laboratories, Inc.
  
•   Agilent Technologies, Inc.
  
•   Beckman Coulter, Inc.
  
•   GenScript
  
•   QIAGEN
  
•   Affinity Biologicals, Inc.
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Antibodies Report Scope

The List of Companies

1. Merck KGaA
2. Cell Signalling Technology, Inc.
3. BD
4. F. Hoffmann-La Roche Ltd
5. Bio-Rad Laboratories, Inc.
6. Agilent Technologies, Inc.
7. Beckman Coulter, Inc.
8. GenScript
9. QIAGEN
10. Affinity Biologicals, Inc.
11. BioLegend
12. Lonza
13. PerkinElmer
14. Danaher Corporation
15. Abcam Plc
16. Thermo Fisher Scientific, Inc.